Revenue: The sum of all revenue fields included for a company's operating activities.
Iovance Biotherapeutics, Inc. (IOVA) had Revenue of $67.45M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
|
Revenue |
$67.45M |
$-91.25M |
|
$38.48M |
|
$28.98M |
|
$162.36M |
|
$-94.90M |
|
$1.24M |
|
$-93.66M |
|
$-93.66M |
|
$-91.25M |
|
$-91.25M |
|
$-91.25M |
|
$-91.25M |
|
$-94.90M |
|
$-84.94M |
|
364.04M |
|
364.04M |
|
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$429.09M |
|
$126.65M |
|
$475.86M |
|
$904.95M |
|
$125.78M |
|
-- |
|
$76.88M |
|
$202.66M |
|
$702.29M |
|
$417.08M |
|
$702.29M |
|
385.46M |
|
| Cash Flow Statement Financials | |
$-249.84M |
|
$46.72M |
|
$244.60M |
|
$122.05M |
|
$164.10M |
|
$42.05M |
|
$49.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.41 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
42.96% |
|
-140.69% |
|
-140.69% |
|
-- |
|
-138.85% |
|
-135.28% |
|
$-274.36M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
0.74 |
|
1.01 |
|
89.07 |
|
-12.99% |
|
-21.88% |
|
-10.08% |
|
-12.99% |
|
$1.82 |
|
$-0.75 |
|
$-0.69 |
|